Strain Report - Rat Genome Database

Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Strain Registration

Strain: SHRSP/A3NCrl

Symbol: SHRSP/A3NCrl
Strain: SHRSP
Substrain: A3NCrl
Full Name: Stroke Prone Rats
RGD ID: 2311051
Citation ID: RRID:RGD_2311051
Ontology ID: RS:0002538
Type: inbred
Available Source: Charles River Laboratories
Origination: Charles River Laboratories
Description: The Spontaneously Hypertensive Stroke Prone Rat (SHRSP) was isolated from Wistar-Kyoto rats by Okamoto and Aoki in 1963. The A3 subline was transferred to the National Institutes of Health in 1975 from Yamori at generation F36. To Charles River in 2002.
Coat Color: Albino
Last Known Status: Unknown





Disease Annotations     Click to see Annotation Detail View

Phenotype Annotations     Click to see Annotation Detail View

Phenotype Values via PhenoMiner     Click to see Annotation Detail View
Options:  View chart  |  Download data table  |  View expanded data table

Clinical Measurement
systolic blood pressure
mean arterial blood pressure
body weight
blood urea nitrogen level
ejection fraction
end-systolic volume
cardiac output
end-diastolic volume
stroke volume
timed urine volume
heart left ventricle weight to body weight ratio
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50)
concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50)
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel
urine albumin excretion rate
urine sodium excretion rate
creatinine clearance
brain infarction volume
percentage of study population displaying hematuria at a point in time
ratio of survivors to total study population during a period of time
concentration of carbachol at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50)
carbachol-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel
BAY 60-4552-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel
concentration of BAY 60-4552 at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50)
GSK2181236A-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel
concentration of GSK2181236A at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50)
time to peak measurement of Gd-DTPA uptake by kidney cortex
percentage of study population displaying glycosuria at a point in time
percentage of study population developing cerebral beta-amyloid deposits during a period of time
percentage of study population developing cerebral small perivascular bleeds during a period of time
percentage of study population developing cerebral small vessel thrombosis and adjacent tissue infarction during a period of time
percentage of study population developing cerebral small perivascular bleeds and beta-amyloid deposits during a period of time
percentage of study population developing cerebral small perivascular bleeds and no beta-amyloid deposits during a period of time
percentage of study population developing renal vascular pathology during a period of time
partial pressure of brain white matter oxygen
ratio of survivors of severe albuminuria to total study population during a period of time
multiregional glomerular filtration rate index
percentage of study population developing kidney tubulointerstitial damage during a period of time
phenylephrine-induced blood vessel contractile force expressed as percent of contractile force generated by potassium chloride

References

References - curated
# Reference Title Reference Citation
1. Comparison of soluble guanylate cyclase stimulators and activators in models of cardiovascular disease associated with oxidative stress. Costell MH, etal., Front Pharmacol. 2012 Jul 5;3:128. doi: 10.3389/fphar.2012.00128. eCollection 2012.
2. Strains registered by Charles River Laboratories International, Inc. Personal communication with Charles River Laboratories
3. Common Impact of Chronic Kidney Disease and Brain Microhemorrhages on Cerebral Aβ Pathology in SHRSP. Pirici D, etal., Brain Pathol. 2017 Mar;27(2):169-180. doi: 10.1111/bpa.12384. Epub 2016 May 30.
4. RGD Strain RSO annotation pipeline RGD Automated Pipelines
5. Kidney pathology precedes and predicts the pathological cascade of cerebrovascular lesions in stroke prone rats. Schreiber S, etal., PLoS One. 2011;6(10):e26287. doi: 10.1371/journal.pone.0026287. Epub 2011 Oct 21.
6. Vascular tight junction disruption and angiogenesis in spontaneously hypertensive rat with neuroinflammatory white matter injury. Yang Y, etal., Neurobiol Dis. 2018 Jun;114:95-110. doi: 10.1016/j.nbd.2018.02.012. Epub 2018 Feb 24.

Region

Strain Samples in RGD with Damaging Variants (Polyphen)
AssemblySample 
Rnor_6.0 SHRSP/A3NCrl (2019) View Damaging Variants
mRatBN7.2 SHRSP/A3NCrl (2019) View Damaging Variants
mRatBN7.2 SHRSP/A3NCrl (2019NG) View Damaging Variants


Additional Information